Faulk Pharmaceuticals, Panther Biotechnology deal

Panther completed the acquisition of Faulk’s pharmaceutical assets for 50,000 Panther shares. The shares are valued at $299,500 based on Panther’s close of $5.99 on July 15, before the deal closed. Pa...